| Dr Jerome Switch, DO | |
|
8950 Telegraph Rd, Taylor, MI 48180-8399 | |
| (313) 295-3937 | |
| Not Available |
| Full Name | Dr Jerome Switch |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 39 Years |
| Location | 8950 Telegraph Rd, Taylor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467464032 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 5101009244 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital - Trenton | Trenton, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Switch Eye Center, Pc | 1355407198 | 2 |
News Archive
Why would a bacteria-killing protein be present in an area of the body that is not normally exposed to bacteria, like the pancreas? Researchers at The Ottawa Hospital and the University of Ottawa puzzled over this question for some time, until they eventually discovered that the protein in question was doing something entirely unexpected - it was actually helping the pancreas regenerate and produce insulin.
Adults with HIV are more likely to continue life-saving treatments if their primary health care providers show respect, unconditional empathy without judgement and demonstrate an ability to partner with patients in decision making to address their goals, a Rutgers study finds.
Kidney Cancer is among the 10 most diagnosed cancers in both men and women in the United States, and it is estimated that more than 60,000 new cases of kidney cancer will be diagnosed in 2015.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Mount Kisco Medical Group, PC (MKMG) to deploy NextGen Ambulatory EHR (Electronic Health Record), NextGen Practice Management, and the NextGen Patient portal.
› Verified 3 days ago
| Entity Name | Switch Eye Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518112978 PECOS PAC ID: 1355407198 Enrollment ID: O20090304000130 |
News Archive
Why would a bacteria-killing protein be present in an area of the body that is not normally exposed to bacteria, like the pancreas? Researchers at The Ottawa Hospital and the University of Ottawa puzzled over this question for some time, until they eventually discovered that the protein in question was doing something entirely unexpected - it was actually helping the pancreas regenerate and produce insulin.
Adults with HIV are more likely to continue life-saving treatments if their primary health care providers show respect, unconditional empathy without judgement and demonstrate an ability to partner with patients in decision making to address their goals, a Rutgers study finds.
Kidney Cancer is among the 10 most diagnosed cancers in both men and women in the United States, and it is estimated that more than 60,000 new cases of kidney cancer will be diagnosed in 2015.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Mount Kisco Medical Group, PC (MKMG) to deploy NextGen Ambulatory EHR (Electronic Health Record), NextGen Practice Management, and the NextGen Patient portal.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerome Switch, DO 8950 Telegraph Rd, Taylor, MI 48180-8399 Ph: (313) 295-3937 | Dr Jerome Switch, DO 8950 Telegraph Rd, Taylor, MI 48180-8399 Ph: (313) 295-3937 |
News Archive
Why would a bacteria-killing protein be present in an area of the body that is not normally exposed to bacteria, like the pancreas? Researchers at The Ottawa Hospital and the University of Ottawa puzzled over this question for some time, until they eventually discovered that the protein in question was doing something entirely unexpected - it was actually helping the pancreas regenerate and produce insulin.
Adults with HIV are more likely to continue life-saving treatments if their primary health care providers show respect, unconditional empathy without judgement and demonstrate an ability to partner with patients in decision making to address their goals, a Rutgers study finds.
Kidney Cancer is among the 10 most diagnosed cancers in both men and women in the United States, and it is estimated that more than 60,000 new cases of kidney cancer will be diagnosed in 2015.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Mount Kisco Medical Group, PC (MKMG) to deploy NextGen Ambulatory EHR (Electronic Health Record), NextGen Practice Management, and the NextGen Patient portal.
› Verified 3 days ago
Lawsen Parker, DO Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 10000 Telegraph Rd, Taylor, MI 48180 Phone: 313-295-5000 | |
Dr. Anju Goyal Aggarwal, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10501 Telegraph Rd Ste 102, Taylor, MI 48180 Phone: 313-228-5341 | |
Dr. Abdalrahman Katranji, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7700 Telegraph Rd, Taylor, MI 48180 Phone: 313-292-0730 Fax: 313-292-1626 | |
Dr. Himanshu Aggarwal, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10501 Telegraph Rd Ste 102, Taylor, MI 48180 Phone: 313-228-5341 | |
Dr. Julie B Reno, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15055 S Plaza Dr, Taylor, MI 48180 Phone: 734-287-2666 Fax: 734-287-3864 | |
Vikisha Hazariwala, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 10000 Telegraph Rd, Taylor, MI 48180 Phone: 313-295-5000 |